Psychosis

Study: Following Cannabis Commercialization, Occasional Use in Those With Psychosis History Increased Much More Than in General Population, Posing Potential Risk
What impact has legalization and commercialization of recreational cannabis had on people with schizophrenia and other disorders involving psychosis? It’s an important question, particularly in view… Read More
In First-Episode Psychosis Patients, Machine Learning Predicted Illness Trajectories to Potentially Improve Outcomes
There is broad agreement among psychiatrists, based on many years of clinical experience, that early treatment following a first episode of psychosis (FEP) provides the best chance for improving a… Read More
A Way to Repair a “Leaky” Blood-Brain Barrier is Tested, Potentially Relevant for Schizophrenia, Autism and Other Disorders
A team of researchers co-led by a three-time BBRF grantee has developed a way to potentially repair the integrity of the blood-brain barrier (BBB), the protective membrane that separates the brain… Read More
With 5 Minutes of Recorded Speech, Machine Learning Attempts to Distinguish Psychosis-Related Disorders from Bipolar Disorder and Major Depression
In a new paper, researchers co-led by a BBRF grantee demonstrate a computer-based method for analyzing just 5 minutes of recorded speech to help distinguish people with a variety of psychiatric… Read More
After First Psychotic Episode, Long-Lasting Injectable Antipsychotics Reduced 3-Year Risk of Relapse, Hospitalization
A new study has added deeper perspective on the important question of whether patients taking long-acting injectable (LAI) antipsychotic medicines after a first episode of psychosis (FEP) have a… Read More